According to market research, the global gelatin market is expected to reach USD 5.1 billion by 2028 and grow at a CAGR of 6.6% during the forecast period until 2023, with the pharmaceutical segment projected to experience the fastest growth. The increasing demand for “free-from” food products and the rising health consciousness among consumers are driving the market’s growth. Moreover, the high protein content in gelatin has led to an increased demand from the nutraceutical and sports nutrition segments.
The animal source segment is expected to hold the largest market share in 2023, as gelatin is commonly obtained through partial hydrolysis of collagen extracted from various animal sources such as marine, mammalian, poultry, and insects. Commercial production of gelatin is primarily sourced from bovine and porcine bones and hides, with marine-sourced gelatin produced and applied on a smaller scale.
Europe is experiencing the highest growth rate in the gelatin market due to the region’s health-conscious consumers and their demand for nutritious and clean-label foods, as well as the growing pharmaceutical industry. Several gelatin manufacturers, such as Gelita AG, PB Leiner, Trobas Gelatine B.V., and Lapi Gelatine S.P.A., are present in Europe, leading to product launches, joint ventures, and acquisitions to meet the growing demand from the food, beverage, and pharmaceutical industries.
Key players in the market include Darling Ingredients, Tessenderlo Group, Nitta Gelatin, Inc., Gelita AG, Weishardt, Lapi Gelatine Spa, India Gelatine & Chemicals Ltd., Trobas Gelatine B.V., Sterling, Roxlor, Suheung, and Ewald Gelatin GmbH.
